Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ionix and Reckitt Benckiser Healthcare develop pain drugs

Executive Summary

Analgesics biotech Ionix Pharmaceuticals Ltd. and Reckitt Benckiser Healthcare (mostly OTC and personal care, part of the large household cleaners company Reckitt Benckiser PLC) will ally to develop three Ionix pain candidates that are based on the mu-opioid agonist buprenorphine.

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • R&D and Marketing (Licensing)

Related Companies